XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.2
Asset Impairment, Exit, and Restructuring Costs
 6 Months Ended
Jun. 30, 2025
Restructuring, Settlement and Impairment Provisions [Abstract]  
Asset Impairment, Exit, and Restructuring Costs Asset Impairment, Exit, and Restructuring Costs
The following table sets forth the charges for the three and six months ended June 30, 2025 and 2024 (in millions).
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Restructuring and exit costs (1)
$126 $— $164 $15 
Impairment charge - other long-lived assets (2)
11 7 11 10 
Total asset impairment, exit, and restructuring costs$137 $7 $175 $25 

(1)On February 4, 2025, the Company announced targeted actions expected to deliver in excess of $500 million of cost savings by fiscal 2029. These include cost optimization and portfolio simplification initiatives designed to help the Company achieve cost efficiencies. Charges associated with these actions, as well as similar initiatives in prior periods, are reflected as restructuring charges in this table. The three months ended June 30, 2025 included restructuring charges (primarily impairment of long-lived assets, impairment of intangible assets, and employee termination benefits) of $119 million, $4 million, $3 million within the Nutrition segment, Ag Services and Oilseeds segment, and Corporate, respectively, presented as specified items. The six months ended June 30, 2025 included restructuring charges (primarily impairment of long-lived assets, impairment of intangible assets, and employee termination benefits) of $123 million, $27 million, $5 million, and $7 million within the Nutrition segment, the Ag Services and Oilseeds segment, the Carbohydrate Solutions segment, and Corporate, respectively, presented as specified items. The six months ended June 30, 2024 included restructuring charges of $3 million and $12 million within the Nutrition segment and Corporate, respectively, both presented as specified items.
(2)The three and six months ended June 30, 2025 included an impairment related to a certain long-lived asset of $11 million within the Nutrition segment, presented as a specified item. The three and six months ended June 30, 2024 included impairments related to certain long-lived assets of $7 million and $10 million, respectively, within the Carbohydrate Solutions and Nutrition segments, presented as specified items.